Six new projects will focus on equity, commercialization policy, new regenerative medicine applications and more
Cutting-edge neural reprogramming strategy could transform the future of MS treatment
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
Medicine by Design-funded researchers are leading the way in ground-breaking cardiac research
Teams are working on a range of innovations including discovering new drug compounds, engineering cell therapies, preventing neurodegeneration and revolutionizing eye treatments
New funding to accelerate previous research efforts including large, multi-disciplinary projects funded by Medicine by Design
Medicine by Design’s Michael Sefton, scientific director, and University Health Network’s Bradly Wouters, executive VP, science and research, publish an op-ed in the Toronto Star.
New program to offer broad training in regenerative medicine including the integration of Medicine by Design's entrepreneurship and commercialization programs.
Transformative research highlighted as part of Heart Month
Event was part of a series that explores convergent approaches in Medicine by Design’s team projects
New initiative to include social scientists, policy experts, industry leaders, patients and others
Research trainees from around the world are encouraged to apply by Jan. 23, 2023
Field leaders come together to explore the "Grand Questions in Regenerative Medicine."
On Dec. 8, the Medicine by Design symposium will explore some of regenerative medicine's most important and challenging questions
Professor Omar F. Khan’s lab group is designing new platforms that deliver RNA to the body, addressing a range of biomedical challenges
